About Samta Kundu
Samta Kundu is a chief operating officer at Strand Therapeutics.
Samta Kundu first appears on SEC filings in 2021.
Experience
This experience comes from Samta Kundu's profile and from SEC filings. For roles taken from filings, the years are when the filings name Samta Kundu in the role, so the role may have started earlier or lasted longer.
Strand Therapeutics Inc. Current
Chief Operating Officer
2019 – Present · Boston, MA
Develops mRNA medicines for people with cancer and autoimmune diseases.
BI
Biotech2050
Biotech2050 Podcast launch volunteer, and Contributing Host of Episode #3
2019
CL
Clora
Head of Business Development
2019
BS
Bristol-Myers Squibb
Senior Director, Strategic Operations, within Bristol-Myers Squibb Discovery organization
2007 – 2019
A2
Adnexus Therapeutics (acquired by Bristol-Myers Squibb in 2007)
Business Development, and business operations (contracts, IP, diligence)
2005 – 2007
CP
Consensus Pharmaceuticals
Business Development
2002 – 2003
DY
Dyax
Business Development
1999 – 2001
GE
Genzyme
Project Manager, Genzyme Tissue Repair
1995 – 1997
LC
L.E.K. Consulting
Analyst & Associate Consultant
1992 – 1995
Key Colleagues at Startups
The people Samta Kundu works with at each company, as listed on that company's latest Form D.
Strand Therapeutics Inc. · Form D, Mar 17, 2026
Jeb Keiper
Independent Board Director
Ala Alenazi
Investment and director
Pegah Ebrahimi
Co-founder & Managing Partner, FPV Ventures, director
Tasuku Kitada
President, Head of R&D, Co-founder, director
Jory Bell
Director
Jacob Becraft
CEO, Co-Founder and director